Moreover, our research findings not only expanded the application prospects of GLP-1RAs in RA diseases, provide a brand-new and pioneering perspective for the precise targeted treatment of RA, but also represent a promising new direction for the future treatment of RA
[DOI] [PubMed] [Google Scholar] 99.Ullrich D, Sieg A, Blume R, Bock KW, Schroter W, et al
The men were between the ages of 58 and 78, and all had severe coronary artery disease
2.3 Search strategy Our search strategy focused on identifying a comprehensive range of studies primarily investigating the impact of SGLT-2i and/or GLP-1 RA drugs on prediabetic or non-diabetic, healthy patients, with a specific focus on those assessing their effect on glycemic measures and diabetes onset